-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN US09075V1026-
BioNTechBörse Börse FrankfurtWKNEURSymbol 22UA
-
BioNTechBörse Xetra FrankfurtEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse BerlinEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse MünchenEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse StuttgartEURSymbol 22UA
-
BIONTECH SE-ADRBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse HamburgEURSymbol 22UA
-
BIONTECH SE-ADRBörse Quotrix System der Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Gettex System der Börse MünchenEURSymbol 22UA
-
ISIN US09075V1026 WKN: A2PSR2USDSymbol BNTX
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US09075V1026
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
BioNTech SEBörse London Stock Exchange
-
ISIN US09075V1026
WKN A2PSR2
Symbol BNTX
Währung
USD
Firmenname
BioNTech SE
Marktkapitalisierung
26.221.596.672
Mitarbeiter
3.165 (+- 43%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.800 oder 4.530 Mitarbeiter
KGV
-99999.99
EBITDA 0
PEGRatio None
Buchwert None
BioNTech outperformed den DAX um +966 % vom 10.10.2019 bis 02.09.2022
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 299,9 EUR +1,45%
Letzte Communitymeinungen
- 5 User waren zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
SaLyn
14.09.2021
-
Karamellsaus_55
29.08.2021
-
Zockrat
29.08.2021
Ein User hat BioNTech abonniert.
Aktionärsstruktur der BioNTech SE
Portrait der BioNTech Aktie
Das Unternehmen BioNTech SE aus Deutschland beschäftigt 3.165 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Die BioNTech Aktie konnte seit dem 10.10.2019 eine Rendite von sage und schreibe 970% erwirtschaften und mit dieser Performance den deutschen Leitindex DAX um 966% outperformed, der im gleichen Zeitraum 4% erwirtschaften konnte.
Mit einem Streubesitz von lediglich 19,7% ist der free float der Aktie vergleichsweise gering. Ein genauerer Blick in die Aktionärsstruktur könnte nützlich sein um den geringen Streubesitz vielleicht aufzuklären.
Das Unternehmen BioNTech SE ist nur in 5 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet BioNTech mit 6,85% im ETF.
5 ETFs die in BioNTech investieren
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
356 News & Informationen zur BioNTech Aktie
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.
Japanese shares end higher as tech tracks Wall Street's gain
Wall Street's main indexes ended higher on Monday, with the Nasdaq closing at an all-time high, after the US Food and Drug Administration (FDA) granted full approval to the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE .
Commodity strategies: Gold, silver, crude, base metals
Here is a look at how different commodities are behaving in todays market
Hawaii governor urges visitors to stay away amid COVID surge By Reuters
Hawaii governor urges visitors to stay away amid COVID surge
Oil rises as full U.S. clearance for COVID-19 vaccine stokes demand hopes
SINGAPORE — Oil prices rose on Tuesday after the U.S. drug regulator granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, stoking investor…
ETMarkets Morning Podcast: Is this the beginning of the end of broader market rally?
Tune in as we tell you what's happening in the market, what's making news this morning, and look at some of the buzzing stocks.
Oil Up, Fuel Demand Outlook Clears Over Full Vaccine Approval By Investing.com
Oil Up, Fuel Demand Outlook Clears Over Full Vaccine Approval
Crude oil rises on fuel demand hopes
Brent crude oil futures gained 66 cents, or 0.9 per cent, to $69.41 a barrel
Oil rises as full US clearance for Covid-19 vaccine stokes fuel demand hopes
Brent crude oil futures gained 66 cents, or 0.9%, to $69.41 a barrel by 0201 GMT, while US West Texas Intermediate (WTI) crude futures increased by 60 cents, or 0.9%, to $66.24 a barrel.
Japanese shares track Wall St higher; SoftBank, chip shares gain
TOKYO — Japanese shares rose on Tuesday, tracking Wall Street’s strong finish overnight, as heavyweights SoftBank Group and chip-related stocks jumped along…
Share Market Live: SGX Nifty Hints At Gains; Aptus Value, Chemplast Sanmar To List Today
Catch all live updates on share prices, index moves, corporate announcements and more from Indian stock markets today.
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes By Reuters
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Oil rises as full U.S. clearance for COVID-19 vaccine stokes fuel demand hopes
SINGAPORE — Oil prices rose on Tuesday after the U.S. drug regulator granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine, stoking investor…
BioNTech Vaccine’s Full Approval By Investing.com
Asian Stocks Up, Hopes Up Over Pfizer/BioNTech Vaccine’s Full Approval
Wall St gains, Nasdaq notches record closing high on full vaccine approval
Wall Street rallied on Monday, and the Nasdaq reached an all-time closing high as sentiment was boosted by full FDA approval of a COVID-19 vaccine and market participants looked ahead to the Jackson Hole Symposium expected to convene later this week. All three major U.S. stock indexes ended the session sharply higher, with the S&P 500 in the session's final minutes just failing to hold what would have been a record-high close.
Equities gain, US dollar falls; Fed seen less eager to taper
The dollar index fell 0.516 per cent to 92.999.. Read more at straitstimes.com.
FDA’s Full Pfizer Approval Fuels a Risk-On Rally
Growth stocks and related exchange traded funds rallied Monday as investors shifted to a risk-on mood in response…
Equities gain, U.S. dollar falls; Fed seen less eager to taper
NEW YORK — Global equity markets rose while the U.S. dollar dipped on Monday as investors grew less concerned that the Federal Reserve would soon begin…
US energy firms weigh in on employee vaccine mandates
The U.S. energy industry is weighing in on COVID-19 vaccine mandates for employees as infections are on the rise following the spread of the Delta variant.
Moderna : S&P 500, Nasdaq on course for record closing highs on vaccine boost
Wall Street rallied on Monday,
coming off a tumultuous week as investors digested full FDA
approval of a COVID-19 vaccine and looked ahead to the Jackson
Hole Symposium expected to convene later this… | August 23, 2021
S&P 500, Nasdaq on course for record closing highs on vaccine boost
NEW YORK — Wall Street rallied on Monday, coming off a tumultuous week as investors digested full FDA approval of a COVID-19 vaccine and looked ahead to the…
Equities gain, U.S. dollar falls as tapering worries recede
NEW YORK — Global equity markets rose while the U.S. dollar dipped on Monday as investor concerns that the Federal Reserve would soon begin changing its…
AMC’s stock shoots up after FDA approval of COVID vaccine
Shares of movie theater operators got a lift Monday, full approval of a COVID-19 vaccine by the Food and Drug Administration helped fuel hopes that increased…
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval For Individuals 16 Years And Older
Pfizer Inc. PFE and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA)
Press Release : Pfizer-BioNTech COVID-19 Vaccine COMIRNATY(R) Receives Full U.S. FDA Approval for Individuals 16 Years and Older
— COMIRNATY is the first COVID-19 vaccine to be granted FDA approval
— Approval is based on a comprehensive submission package including
six-month efficacy and safety data after… | August 23, 2021
U.S. FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine
The U.S. drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine that had earned emergency-use authorization in December,…
Wall Street rebounds as banks, energy surge
Wall Street’s main indexes rose on Monday, with banks and energy shares leading the gains, as investors returned to riskier assets after a sharp selloff last…
Stocks rally as investors eye Fed's Jackson Hole event
Stocks rallied as investors eyed a key Federal Reserve event that could lay the framework to begin the central bank's tapering process.
Doctors question the optics and the scientific rationale behind the plan for COVID-19 booster shots in the U.S.
The decision to give out extra doses of Moderna and Pfizer’s COVID-19 vaccines pits federal health officials who say the shots may not protect people from…
25 Stocks Moving in Monday's Pre-Market Session
Gainers Greenpro Capital Corp. (NASDAQ:GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the c…
Bitcoin, Pfizer COVID-19 Vaccine, Dogecoin, NFT And Disney: 5 Headlines From Weekend You May Have Missed
There has been some exciting news from the biotech, cryptocurrency and corporate sectors that investors may have missed over the weekend. Here is a quick …
A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises Over 3%
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones surged more than 200 points in the previous sessio…
5 Stocks To Watch For August 23, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Palo Alto Networks Inc (NYSE:PANW) to report quarterly earnings …
Mounting evidence that delta variant is winning – case for boosters is building
The rollout of a third dose of Covid vaccine has sparked debate on ethical and political grounds, since a large swath of the human population is yet to receive…
Beating back Delta variant will take extra Covid shot for privileged few
The most-infectious coronavirus variant to emerge so far is in a race with the human immune system, and there’s mounting evidence that delta is winning — at least initially
The case for a booster shot is building, even if privileged few get it
Read more about The case for a booster shot is building, even if privileged few get it on Business Standard. The reason is delta. The most-infectious coronavirus variant to emerge so far is in a race with the human immune system, and there's mounting evidence that delta is winning
World may never reach herd immunity against Covid-19
As Covid-19 surged last year, governments worldwide touted the hope of “herd immunity,” a promised land where the virus stopped spreading exponentially because enough people were protected against it. That’s now looking like a fantasy. The thinking was that the pandemic would ebb and then mostly fade once a chunk…
Pfizer, Netflix, Amazon.com: Stocks That Defined the Week
Here are seven major companies whose stocks moved on the week’s news.